Melatonin Market Growth, Trends, and Key Insights 2024-2028

The Global Melatonin Market is projected to expand significantly, with an estimated increase of USD 924.9 million between 2023 and 2028, registering a CAGR of 10.03%. The rising prevalence of sleep disorders, including insomnia, jet lag, and circadian rhythm disorders, along with the increasing incidence of neurodegenerative diseases and cancer, is driving market growth. Additionally, melatonin's role as an antioxidant and its integration into food products further contribute to the expansion of the market.However, the market faces challenges due to government regulations that vary across regions, affecting market access and pricing. Despite this, the demand for melatonin supplements, particularly melatonin gummies, continues to rise as more individuals seek natural sleep solutions.

For more details about the industry, get the PDF sample report for free

Market Segmentation

The melatonin market is segmented as follows:

By Product:

Pharmaceutical-grade melatonin
Food-grade melatonin

By Geography:

North America
- Canada
- United States
Europe
- Germany
Asia-Pacific (APAC)
- China
- Japan
South America
Middle East and Africa

Product Insights

The pharmaceutical-grade melatonin segment is expected to witness significant growth due to its widespread use in treating sleep disorders such as insomnia, jet lag, and circadian rhythm disorders. This segment accounted for USD 776.40 million in 2018 and has shown steady growth.

Melatonin is available in various forms, including capsules, tablets, liquids, balms, roll-ons, vaping products, and gummies. The rise in e-commerce and an increasing health-conscious population contribute to the dominance of pharmaceutical-grade melatonin. Consumers prefer rapid-action supplements to combat sleep disorders, making prescription-based melatonin products a preferred choice.

Regional Market Trends

North America (34% Market Share Contribution)

The United States and Canada are key markets due to the high prevalence of sleep disorders.
One-third of U.S. adults experience insomnia, leading to an increased demand for melatonin supplements.
Growing awareness of sleep health and the therapeutic benefits of melatonin fuels market growth.
Melatonin is also used for anxiety, depression, migraines, and oxidative stress-related conditions.

Europe

Germany leads the European market with increasing use of melatonin for sleep disorders and aging-related health issues.

Asia-Pacific (APAC)

China and Japan experience high demand due to aging populations and increasing sleep disorders.

South America & Middle East and Africa

The market is expanding due to rising health awareness and the adoption of natural sleep aids.

Market Dynamics

Drivers

Increasing Human Life Expectancy and Longer Working Hours:
- The aging population is rising in countries like the United States, Japan, South Korea, China, and Germany.
- Many individuals continue working beyond retirement age, leading to higher stress levels and sleep disorders.
- Healthcare professionals recognize melatonin as a safe sleep aid, further driving market demand.

Trends

Rise in the Geriatric Population:
- Over 50% of adults aged 65+ experience chronic sleep-related issues.
- Sleep disturbances in older adults are linked to Type 2 diabetes, cardiovascular diseases, and neurodegenerative disorders.
- Melatonin supplements are increasingly preferred as natural alternatives to pharmaceutical sleep aids.

Challenges

Regulatory Restrictions and Government Regulations:
- FDA regulations in the U.S. and restrictions by the American Academy of Sleep Medicine (AASM) limit market expansion.
- The UK’s National Health Service (NHS) does not routinely fund melatonin for jet lag, impacting product accessibility.
- Approximately 70 million Americans suffer from sleep disorders, yet regulatory hurdles remain a key challenge.

Get more details by ordering the complete report